dibenzoylmethane has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, DA; Bushell, M; Halliday, M; Mallucci, GR; Molloy, C; Moreno, JA; Ortori, CA; Radford, H; Smith, E; Verity, NC; Zents, KAM | 1 |
| Barve, A; Foster, B; Hao, X; Hong, JL; Huang, MT; Khor, TO; Kong, AN; Lin, W; Newmark, HL; Yu, S | 1 |
| Choshi, T; Hibino, S; Hori, O; Matsuura, N; Murakami, R; Uchida, M; Yamada, M | 1 |
3 other study(ies) available for dibenzoylmethane and Disease Models, Animal
| Article | Year |
|---|---|
Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice.
Topics: Animals; Behavior, Animal; Chalcones; Disease Models, Animal; eIF-2 Kinase; Frontotemporal Dementia; Memory Disorders; Mice; Neuroprotective Agents; Prion Diseases; Protein Kinase Inhibitors; Signal Transduction; Trazodone; Unfolded Protein Response | 2017 |
Dietary feeding of dibenzoylmethane inhibits prostate cancer in transgenic adenocarcinoma of the mouse prostate model.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Cycle; Chalcones; Diet; Dietary Supplements; Disease Models, Animal; Female; Humans; Male; Mice; Mice, Transgenic; Phosphorylation; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms | 2009 |
Efficacy of dibenzoylmethane derivatives in protecting against endoplasmic reticulum stress and inhibiting nuclear factor kappa B on dextran sulfate sodium induced colitis in mice.
Topics: Animals; Chalcones; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Endoplasmic Reticulum; Feces; Female; Mice; Mice, Inbred BALB C; NF-kappa B; Occult Blood; Severity of Illness Index | 2010 |